Cargando…
Does the political will exist to bring quality-assured and affordable drugs to low- and middle-income countries?
Background: Increased coverage with antiretroviral therapy for people living with HIV in low- and middle-income countries has increased their life expectancy associated with non-HIV comorbidities and the need for quality-assured and affordable non-communicable diseases drugs . Funders are leaving ma...
Autores principales: | Beck, Eduard J., Mandalia, Sundhiya, DongmoNguimfack, Boniface, Pinheiro, Eloan, ‘t Hoen, Ellen, Boulet, Pascale, Stover, John, Gupta, Aashta, Juneja, Sandeep, Habiyambere, Vincent, Ghys, Peter, Nunez, Cesar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484498/ https://www.ncbi.nlm.nih.gov/pubmed/30983547 http://dx.doi.org/10.1080/16549716.2019.1586317 |
Ejemplares similares
-
Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025
por: Gupta, Aastha, et al.
Publicado: (2016) -
Affordability of adult HIV/AIDS treatment in developing countries: modelling price determinants for a better insight of the market functioning
por: Sagaon-Teyssier, Luis, et al.
Publicado: (2016) -
Forecasting the global demand for HIV monitoring and diagnostic tests: A 2016-2021 analysis
por: Habiyambere, V., et al.
Publicado: (2018) -
Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016
por: Hutin, Yvan, et al.
Publicado: (2018) -
A research agenda to promote affordable and quality assured medicines
por: Kaplan, Warren A, et al.
Publicado: (2014)